A Study of PLX51107 in Advanced Malignancies | Aplastic Anemia and MDS International Foundation

Clinical Trial: NCT02683395

A Study of PLX51107 in Advanced Malignancies
For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov:
Purpose: 

The purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the investigational drug PLX51107 in subjects with advanced solid tumors (including lymphoma), acute myeloid leukemia (AML), or high-risk myelodysplastic syndrome (MDS).

Status: 
Recruiting
Study Date: 
Tue, 03/01/2016 to Mon, 01/01/2018
Intervention: 
Drug: PLX51107